Regeneron (REGN) Halted Ahead of FDA Panel Review of Praluent
Go back to Regeneron (REGN) Halted Ahead of FDA Panel Review of Praluent| Regeneron (NASDAQ: REGN) | Delayed: 826.17 -7.87 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $834.04 | 52 Week High | $592.36 | |||
| Open | $834.51 | 52 Week Low | $325.35 | |||
| Day High | $834.70 | P/E | 216.84 | |||
| Day Low | $824.63 | EPS | $3.81 | |||
| Volume | 71,809 | |||||

